CNIO - Spanish National Cancer Research Centre
Ivana Zagorac BC-MSLcert PhD is a distinguished researcher currently serving as a Postdoctoral Investigator at the Spanish National Cancer Research Centre (CNIO) in the H12O-CNIO Cancer Immunotherapy Clinical Research Unit since January 2023, and as a Postdoctoral Research Scientist at Hospital 12 de Octubre since January 2022. Previously, Ivana held the position of Postdoctoral Research Scientist at the CNIC - Spanish National Center for Cardiovascular Research from July 2017 to December 2021, focusing on the role of Notch signaling and hypoxia in tumor angiogenesis. Earlier experience includes a tenure as a Pre-Doc Research Assistant at CNIO from September 2011 to February 2017, contributing to the identification of biomarkers for early detection of triple-negative breast cancer. Educational credentials include a PhD in Molecular Biology from Universidad Autónoma de Madrid and a B.Sc. and MSc in Molecular Biology from the University of Belgrade. Additionally, Ivana has participated in various projects as a Visiting Scholar at prominent institutions.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.